A Multicenter Real-world Study of Screening of Cervical Cancer Based on Photoelectric Detection

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-65
SponsorLei Li

About this trial

The main purpose of this study is to explore the accuracy and clinical value of fluorescent photoelectric cervical lesion image detector as a screening and shunt tool for cervical lesions through a multi-center, large-sample real-world study with histopathology as the gold standard. The secondary purpose of the study was to verify the coincidence of the fluorescent photoelectric cervical lesion image detector with traditional colposcopic chemical staining.

This study is expected to include 20,000 participants with definite histological results, and compare the specificity and sensitivity, negative predictive value and positive predictive value of three cervical lesion screening methods, such as fluorescent photoelectric cervical lesion image detector, HPV nucleic acid detection and cytology detection. The advantages and disadvantages of fluorescent photoelectric cervical disease image detector, HPV nucleic acid detection and cytology examination were analyzed, and their application scenarios were provided to provide evidence-based medical support for the establishment of comprehensive prevention and treatment system of cervical cancer suitable for China's national conditions.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

1. Age ≥ 18 years old, ≤ 65 years old, with a complete cervix without deformity.

2. Have clear cervical cancer screening results, meet HPV16/18 (+) or high-risk HPV (+), and cervical cytology results ≥ ASC-US.

3. Fully informed and agreed to participate in the study.

4. No history of cervical cancer disease and cancer in other parts.

Disqualifiers

1. Cannot meet all Inclusion Criteria.

2. There is clear immunosuppression, such as HIV infection or organ transplantation, etc., and the vagina or cervix is in the acute inflammation stage。

3. There are serious bleeding diseases or photosensitive diseases such as abnormal coagulation.

Trial population

This is a multicenter, parallel controlled, cross-sectional real-world study based on the population of a hospital gynecology clinic (gynecology clinic/colposcopy room).

Trial design

Design model

Case-crossover

Time perspective

Cross-sectional

Treatments tested in this trial

  • Detection of Cervical Lesions by Fluorescence Photoelectric Image

    Diagnostic test

    The enrolled patients underwent fluorescence photoelectric cervical lesion image detection, followed by colposcopy and biopsy to obtain histopathological results. The results of fluorescence photoelectric image detection were compared with histopathological results, and at the same time compared with HPV and TCT results at the time of enrollment.

Treatment groups

20,000 Participants
are divided into 1 treatment group
Group A: The cervical lesion was detected by fluorescence photoelectricity in the enrolled patients1 intervention

Trial outcomes

Primary outcomes

1

Accuracy of tissue lesion screening based on photoelectric detection

The sensitivity, specificity, positive predictive value and negative predictive value of fluorescence photoelectric cervix lesion image detector were calculated by using CIN 2 + as the gold standard determined by histopathology, and compared with those of HPV and TCT.

Time frame
The data collection time for each subject is approximately 7 days, starting from the day of each subject's enrollment and ending when the pathology report of the cervical tissue biopsy under colposcopy is issued.

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Lei Li

Lead sponsor

Peking Union Medical College Hospital

Sponsor institution

This trial is not recruiting at the moment. You can still explore other options: